BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer

Hepatobiliary Cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben‐Josef et al. · Journal of the National Comprehensive Cancer Network · 2009 · 2.3K citations · Full text

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

Anirudh Prahallad, Chong Sun, Sidong Huang et al. · Nature · 2012 · 2K citations · Full text

Gastrointestinal Oncology, Medicine, Feedback Activation +8

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Daniel J. Sargent, Silvia Marsoni, Geneviève Monges et al. · Journal of Clinical Oncology · 2010 · 1.6K citations · Full text

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Kras Mutations, Gastrointestinal Oncology, Medicine +13

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

Shuji Ogino, Katsuhiko Nosho, Gregory J. Kirkner et al. · Gut · 2008 · 777 citations · Full text